Eiji Nakano

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Venues

The Journal of dermatology

Japanese journal of clinical oncology

Experimental dermatology

Dermatologic therapy

Kobe University Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kobe University Hospital Aug 01 2019

Japan

assistant professor :: dermatology

Publications

Seiji Tsuruta, Dai Ogata, Kenjiro Namikawa, Eiji Nakano, Naoya Yamazaki
A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment options. Japanese journal of clinical oncology (2024)
Naohito Hatta, Dai Ogata, Jun Asai, Takeo Maekawa, Takamichi Ito, Tatsuya Takenouchi, Yukiko Kiniwa, Azusa Miyashita, Takuya Miyagawa, Ikko Muto, Yuki Yamamoto, Tohru Nagano, Yoshio Kiyohara, Eiji Nakano, Shuichi Ohe, Buntaro Yamaguchi, Masahiro Fukuyama, Taisuke Matsuya, Arata Tsutsumida, Kenjiro Namikawa, Naoya Yamazaki
Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental dermatology 33 (2) (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology (2024)
Eiji Nakano, Akira Takahashi, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan. The Journal of dermatology (2024)
Naohito Hatta, Dai Ogata, Jun Asai, Takeo Maekawa, Takamichi Ito, Tatsuya Takenouchi, Yukiko Kiniwa, Azusa Miyashita, Takuya Miyagawa, Ikko Muto, Yuki Yamamoto, Tohru Nagano, Yoshio Kiyohara, Eiji Nakano, Shuichi Ohe, Buntaro Yamaguchi, Masahiro Fukuyama, Taisuke Matsuya, Arata Tsutsumida, Kenjiro Namikawa, Naoya Yamazaki
Recent treatment and prognosis in 643 patients with extramammary Paget's disease. Experimental dermatology 33 (2) (2024)
Shogo Wada, Eiji Nakano, Miho Nakajima, Satsuki Kishikawa, Akihiko Yoshida, Taisuke Mori, Atsuyoshi Osada, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. The Journal of dermatology (2024)
Yusuke Muto, Taku Fujimura, Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Akira Hashimoto, Yumi Kanbayashi, Yoshihide Asano, Naoya Yamazaki
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients. The Journal of dermatology 51 (9) (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology 51 (3) (2024)
Yusuke Muto, Taku Fujimura, Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Eiji Nakano, Shunichi Jinnai, Akira Hashimoto, Yumi Kanbayashi, Yoshihide Asano, Naoya Yamazaki
Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients. The Journal of dermatology (2024)
Eiji Nakano, Akira Takahashi, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan. The Journal of dermatology 51 (9) (2024)
Shogo Wada, Eiji Nakano, Miho Nakajima, Satsuki Kishikawa, Akihiko Yoshida, Taisuke Mori, Atsuyoshi Osada, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. The Journal of dermatology 51 (6) (2024)
Akemi Fukuda, Dai Ogata, Yoichi Oshima, Eiji Nakano, Kenjiro Namikawa, Motoaki Komatsu, Akira Nakamura, Kohei Sugiura, Naoya Yamazaki
Grade 3 acute kidney injury caused anti-glomerular basement membrane nephritis during immune checkpoint inhibitor treatment for melanoma. The Journal of dermatology (2024)
Kenjiro Namikawa, Eiji Nakano, Dai Ogata, Naoya Yamazaki
Long-term survival with systemic therapy in the last decade: Can melanoma be cured? The Journal of dermatology 51 (3) (2024)
Eiji Nakano, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
Merkel cell carcinoma: a review of clinical management with focus on Asian patients. Japanese journal of clinical oncology (2023)
Mariko Tsujimoto, Eiji Nakano, Yuka Nakazawa, Fumio Kanda, Takehiro Ueda, Tomoo Ogi, Chikako Nishigori
A case of Cockayne syndrome with unusually mild clinical manifestations. The Journal of dermatology (2023)
Go Omura, Kenjiro Namikawa, Toshihiko Sakai, Kohtaro Eguchi, Yoshifumi Matsumoto, Azusa Sakai, Kenya Kobayashi, Eiji Nakano, Dai Ogata, Fumihiko Matsumoto, Taisuke Mori, Naoya Yamazaki, Seiichi Yoshimoto
Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan. Japanese journal of clinical oncology (2023)
Shogo Wada, Tomone Watanabe, Taisuke Ishii, Yuichi Ichinose, Ryoko Rikitake, Dai Ogata, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki, Takahiro Higashi
A retrospective study of sentinel lymph node biopsy for skin cancer in Japan: Comparison with breast cancer and evaluation of factors related to its use. Cancer medicine (2023)
Ayano Tanigawa, Takashi Fukumoto, Shinya Imamura, Korefumi Nakamura, Tomonori Tanaka, Tomoo Itoh, Eiji Nakano, Chikako Nishigori, Akiharu Kubo
CD4/CD8 double-negative T-cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy. The Journal of dermatology (2023)
Akira Takahashi, Kenjiro Namikawa, Dai Ogata, Shunichi Jinnai, Eiji Nakano, Naoya Yamazaki
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma. The Journal of dermatology (2022)
Kenshiro Yamanaka, Kenji Sato, Taro Masaki, Eiji Nakano, Chikako Nishigori
Basal cell carcinoma derived from epidermal cyst of the knee of a patient with xeroderma pigmentosum group C. The Journal of dermatology 49 (7) (2022)
Mao Okumura, Eiji Nakano, Kenjiro Namikawa, Akira Takahashi, Yutaka Fujiwara, Naoya Yamazaki
Efficacy of surgery for skin cancers initially suspected to be carcinoma of unknown primary: a retrospective observational study. International journal of dermatology (2021)
Ryosuke Mochizuki, Yumi Oka, Shinya Hashimoto, Erina Shiraki, Mariko Ogo, Haruki Jimbo, Eiji Nakano, Susumu Fujiwara, Tohru Nagano, Chikako Nishigori
A case of recessive dystrophic epidermolysis bullosa treated with a cultured epidermal autograft. The Journal of dermatology 48 (4) (2021)
Toshihisa Hamada, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Noriko Makita, Katsunori Manaka, Yoshihito Shimoyama, Makoto Sugaya
Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance. The Journal of dermatology (2021)
Yutaka Takaoka, Mika Ohta, Satoshi Tateishi, Aki Sugano, Eiji Nakano, Kenji Miura, Takashi Suzuki, Chikako Nishigori
In Silico Drug Repurposing by Structural Alteration after Induced Fit: Discovery of a Candidate Agent for Recovery of Nucleotide Excision Repair in Xeroderma Pigmentosum Group D Mutant (R683W). Biomedicines 9 (3) (2021)
Eiji Nakano, Akira Takahashi, Kenjiro Namikawa, Yusuke Muto, Shunichi Jinnai, Yuta Kage, Haruki Mizuta, Arata Tsutsumida, Naoya Yamazaki
Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study. The Journal of dermatology 47 (6) (2020)
Susumu Fujiwara, Eiji Nakano, Korefumi Nakamura, Ken Washio, Kanako Ogura, Chikako Nishigori
Pazopanib as a potential chemotherapy for cutaneous angiosarcoma: A case series of 10 patients from a single institution. The Journal of dermatology 47 (7) (2020)
Haruki Mizuta, Eiji Nakano, Akira Takahashi, Takafumi Koyama, Kenjiro Namikawa, Naoya Yamazaki
Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review. Dermatologic therapy 33 (3) (2020)

Eiji Nakano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eiji Nakano